Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries’ research arm Sun Pharma Advanced Research Company (SPARC) has collaborated with China’s biotech firm HitGen to identify novel small molecule leads for targets of interest. Under the terms of the agreement, HitGen will receive upfront payment and will be eligible for certain milestone payments.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.